Belangrijkste concepten
HPV vaccine Cervarix is highly effective in preventing cervical cancer in women vaccinated between ages 12 and 13 years.
Statistieken
"No cases of cervical cancer were found among women who were immunized at ages 12 or 13 years, no matter how many doses they received."
"Women who were immunized between ages 14 and 18 years and received three doses had fewer instances of cervical cancer compared with unvaccinated women regardless of deprivation status (3.2 cases per 100,00 women vs 8.4 cases per 100,000)."
Citaten
"Continued participation in screening and monitoring of outcomes is required, however, to assess the effects of changes in vaccines used and dosage schedules since the start of vaccination in Scotland in 2008 and the longevity of protection the vaccines offer."